A Policy Review for National Cervical Cancer Elimination Plan as the Primary Prevention of Cervical Cancer in Indonesia: Perspective of HPV Vaccination Recommendations from the Centers for Disease Control and Prevention Recommendation
Cermin Dunia Kedokteran · 15.07.2026 · 53 (07) · 492-496
DOI: 10.55175/cdk.v53i07.1675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cermin Dunia Kedokteran, online erschienen am 15.07.2026. Verfasst von Fitriyadi Kusuma und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Cervical cancer is the second most prevalent cancer among women in Indonesia and ranks third globally. It accounts for 7.5% of cancer-related deaths worldwide, with a notable impact in developing nations like Indonesia. The primary cause is high-risk Human Papillomavirus (HPV); however, the risk can be lowered through vaccination. This review aims to evaluate Indonesia's policy for implementing a national HPV vaccination program targeting school-aged children and assess its conformity with CDC guidelines.
Methods
The study involved an extensive review of literature, as well as international and Indonesian policy documents.
Results
The CDC recommends HPV vaccination for individuals aged 9-26, ideally beginning at 11 or 12 years old. In line with this, Indonesia has included the HPV vaccine in its national immunization schedule. The Indonesian Ministry of Health intends to require HPV vaccination for school-aged children, aiming for full national implementation by 2023. This reflects Indonesia's strong commitment to a comprehensive cervical cancer prevention strategy. The policy's alignment with CDC recommendations emphasizes the country's dedication to primary prevention through HPV vaccination.
Conclusion
By enforcing HPV vaccination for school-aged children, Indonesia aims to substantially decrease the incidence and mortality rates associated with cervical cancer. This policy represents a significant advance in the fight against cervical cancer in Indonesia and could serve as a model for other countries contending with similar public health issues.
Zitieren
APA
Kusuma, F., & Suryoadji, K. A. (2026). A Policy Review for National Cervical Cancer Elimination Plan as the Primary Prevention of Cervical Cancer in Indonesia: Perspective of HPV Vaccination Recommendations from the Centers for Disease Control and Prevention Recommendation. Cermin Dunia Kedokteran, 53(07), 492-496. https://doi.org/10.55175/cdk.v53i07.1675
Vancouver
Kusuma F, Suryoadji KA. A Policy Review for National Cervical Cancer Elimination Plan as the Primary Prevention of Cervical Cancer in Indonesia: Perspective of HPV Vaccination Recommendations from the Centers for Disease Control and Prevention Recommendation. Cermin Dunia Kedokteran. 2026;53(07):492-496. doi:10.55175/cdk.v53i07.1675
BibTeX
@article{Kusuma2026,
author = {Kusuma, Fitriyadi and Suryoadji, Kemal Akbar},
title = {A Policy Review for National Cervical Cancer Elimination Plan as the Primary Prevention of Cervical Cancer in Indonesia: Perspective of HPV Vaccination Recommendations from the Centers for Disease Control and Prevention Recommendation},
journal = {Cermin Dunia Kedokteran},
year = {2026},
volume = {53},
number = {07},
pages = {492--496},
doi = {10.55175/cdk.v53i07.1675}
}
EUVIMED